CClinicalTrials.gg
Status unknownNCT02793518Updated Jun 8, 2016

Mental Time Travel and Identity in Bipolar Disorder Patients

An interventional study of psychological tests in Bipolar Disorder, sponsored by CHU de Reims. Status unknown at 1 site in France. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-06-08.

Sponsored by CHU de Reims · Not applicable and Interventional

The sponsor has not verified this record recently (last verified May 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Self-defining memories (SDMs) are memories that are still important today to understand who the investigators are and participate to the maintain of personal identity. SDMs are also linked to our capacity to project ourselves into the future. In bipolar disorder, life events play an important role in the course and outcome of the disease. the study is the first to investigate SDMs and self-defining future projections in a population of remitted patients with bipolar disorder.

Read the detailed description

Study design: case / control study in inclusion prospective, single center. population:

  • A group of 30 patients aged 18 to 60 years and followed in the psychiatry department of adult CHU Reims for bipolar disorder type I (DSM-IV criteria).
  • A group of 30 control subjects with no personal or family history of severe psychiatric disorder (bipolar disorder, schizophrenia or schizoaffective disorder), recruited from the staff of the University Hospital of Reims, the medical faculty of Reims or Marnais center health promotion of Reims, via the intranet and paper display.

The two groups will be matched for age (± 3 years), sex and educational level (± 2 years).

Plan of investigation: the study will be done in two visits:

  • The first visit by a psychiatrist for:

    • information on the objectives and the methods of research, verification criteria for inclusion and non-inclusion and participation of obtaining consent (written consent)
    • comprehensive psychiatric evaluation and procurement different scales (anxiety scale, Hamilton depression scale, evaluation of verbal IQ, ...).
  • 2nd visit, a maximum of 15 days after the first visit by a psychologist, neuropsychologist for the award of the memories of love and future projections defining self: the experimenter asks the subjects to relate memories 3 and 3 future projections. It is important personal events that arouse strong emotions and that the subjects often think.

Memories and projections reported by the subjects are then classified according to their emotional valence, their content, significance and degree of integration itself.

02

Conditions studied

  • Bipolar Disorder

Browse trials for

03

In context

Bipolar Disorder

1,601 studies on the registry are indexed under Bipolar Disorder; 254 are open to participants now.

This study's planned enrollment of 60 is close to the median of 64 across 1,223 interventional studies indexed under Bipolar Disorder.

Browse Bipolar Disorder studies →

Lead sponsor

CHU de Reims is the lead sponsor of 267 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

BD patients :

  • Men or women, right-handed, with a diagnosis of type 1 bipolar disorder, according to the DSM-IV criteria, aged from 18 to 60 years-old
  • Native French speaker
  • Affiliated to the social security
  • Accepting the study after reading the information note and signing the consentment form

Healthy Controls (HC):

  • Men or women, right-handed, aged from 18 to 65 years-old
  • Native French speaker
  • Affiliated to the social security
  • Accepting the study after reading the information note and signing the consentment form

Exclusion criteria

Exclusion criteria

BD patients :

  • A recent alcohol and/or drug abuse or dependence
  • A significant general medical illness, including neurological disorders or head trauma
  • A sensorial impairment (visual and/or hearing)

HC:

  • A personal or first-degree-relative history of bipolar disorder, schizophrenia or schizoaffective disorder according to DSM-IV
  • A recent alcohol and/or drug abuse or dependence
  • A significant general medical illness, including neurological disorders or head trauma
  • A sensorial impairment (visual and/or hearing)
05

Study design

Phase
Not applicable
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Bipolar Disorder patients

    Behavioral: psychological tests

  • Experimental
    Healthy Controls

    Behavioral: psychological tests

Interventions

  • Behavioralpsychological tests
06

What researchers measure

Primary outcomes

  1. psychological test : Mini International Neuropsychiatric Interview (M.I.N.I.)

    Time frame: Day 01

  2. psychological test : State - Trait Anxiety Inventory Form Y

    Time frame: day 15

  3. psychological test : Hamilton Depression Scale (HAM-D)

    Time frame: Day 01

  4. psychological test : Mill Hill Vocabulary Scale

    Time frame: day 15

07

Study locations

1 of 1 sites recruiting
  • Chu Reims
    Reims, 51092, France
    • Delphine RAUCHER-CHENE · Contact
    • Sarah BARRIERE · Contact
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 8, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02793518
Lead sponsor
CHU de Reims
Responsible party
Sponsor
First posted
Jun 8, 2016
Start date
May 2013
Primary completion
Oct 2016 (estimated)
Completion
Oct 2016 (estimated)
Last update
Jun 8, 2016

Study contacts

Delphine RAUCHER-CHENE
Contact
draucherchene@chu-reims.fr
Sarah BARRIERE
Contact
sbarriere@chu-reims.fr

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion